미국의 의료기기 아웃소싱 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, 용도별, 클래스별, 국가별, 부문별 예측(2025-2030년)

U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis Report By Service, By Application, By Class, By Country, And Segment Forecasts, 2025 - 2030

US $ 3,950 ￦ 5,471,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 4,950 ￦ 6,857,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 6,950 ￦ 9,627,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

미국 의료기기 아웃소싱 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 미국 의료기기 아웃소싱 시장 규모는 2030년에 634억 달러에 달할 것으로 예상되며, 예측 기간의 CAGR은 13.0%를 보일 것으로 예측됩니다.

이 시장은 해외 동향 증가, 하이테크 의료기기에 대한 수요 증가, 미국의 의료기기에 대한 엄격한 규제의 결과로 성장하고 있습니다.

의료기기 산업은 항상 경쟁이 심하고 관상동맥 스텐트, 정형외과기기, 상처치료 등의 카테고리가 성숙을 향하고 있습니다. 이를 통해 시장 점유율을 얻고 있습니다. 과제가 쌓여 시장 역학이 변화하고 있기 때문에 의료기기 제조업체는 비용 절감, 비즈니스 리스크 관리, 서비스 제공 개선을 목적으로 아웃소싱 비즈니스 모델을 선택할 가능성이 높습니다.

정부 당국은 필수 불가결한 장비의 연구 개발을 위한 자금을 증액하고 있으며, 이것이 시장을 견인하고 있습니다.

예를 들어, 2023년 2월 현재 2만 5,033건 이상의 의료기기 조사가 Clinical Trials .gov에 등록되어 있습니다. 의료기기 기업은 숙련된 노동력과 선진적 인프라를 이용할 수 있는 것 외에 양질의 서비스를 제공하는 CRO가 많이 존재하기 때문에 미국에서 조사를 실시했습니다. 이 모든 요인은 팬데믹 후 시장을 뒷받침할 것으로 예측됩니다.

미국 의료기기 아웃소싱 시장 보고서 하이라이트

• 미국의 의료기기 아웃소싱 산업은 FDA 규제의 엄격화로 개발 도상에 있으며 제조업체는 전문적인 컴플라이언스 지원을 요구해야 합니다.
• 규제 요건의 진화, 비용 압력, 시장 출시까지의 시간 단축의 필요성으로 인해 시장은 빠르게 변화하고 있습니다.
• 미국 의료기기 아웃소싱 산업은 비용 억제 압력, 엄격한 규제 준수 및 장비 개발의 복잡성에 의해 견인되고 있습니다.
• 2024년에는 수탁 제조 부문이 46.74%의 최대 점유율을 차지했습니다. 이 부문의 성장은 비용 압력 증가, FDA 규제 요건의 엄격화, 의료기기의 복잡화로 인한 것입니다.
• 용도별로 순환기 부문은 2024년 시장을 독점했습니다. 심혈관 질환(CVDs)의 높은 유병률로 인한 심혈관 장비 수요 증가는 이러한 장비의 아웃소싱 성장으로 인한 것입니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/보조시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 산업의 과제
• 기술의 진보
• 규제 프레임워크
• 가격 모델 분석
• 시장 분석 도구
  • Porter's Five Forces 분석
  • SWOT 분석에 의한 PESTEL
  • COVID-19의 영향 분석

제4장 미국의 의료기기 아웃소싱 시장 : 서비스별, 추정·동향 분석

• 미국 의료기기 아웃소싱 시장(서비스별) : 부문 대시보드
• 미국 의료기기 아웃소싱 시장(서비스별) : 변동 분석
• 서비스별, 2018-2030년
• 품질 보증 서비스
  • 품질 보증 서비스 시장의 추정과 부문 예측, 2018-2030년
• 규제 관련 서비스
  • 규제 관련 업무 서비스 시장의 추정과 부문 예측, 2018-2030년
  • 임상 검사 신청과 제품 등록
  • 규제 문서의 집필과 출판
  • 법적 대리
  • 기타
• 제품 설계 및 개발 서비스
  • 제품 설계 및 개발 서비스 시장 추정과 부문 예측, 2018-2030년
  • 설계 및 엔지니어링
  • 기계가공
  • 성형
  • 포장
• 데이터 관리 및 생물통계학
  • 데이터 관리와 생물통계 시장 추정과 부문 예측, 2018-2030년
• 제품 검사 및 멸균 서비스
  • 제품 검사와 멸균 서비스 시장 추정과 부문 예측, 2018-2030년
• 제품 구현 서비스
  • 제품 구현 서비스 시장 추정과 부문 예측, 2018-2030년
• 제품 업그레이드 서비스
  • 제품 업그레이드 서비스 시장의 추정과 부문 예측, 2018-2030년
• 제품 유지보수 서비스
  • 제품 보수 서비스 시장의 추정과 부문 예측, 2018-2030년
• 계약 제조
  • 계약 제조 시장의 추정과 부문 예측, 2018-2030년
  • 부속품 제조
  • 조립 제조
  • 부품 제조
  • 기기 제조
• 기타
  • 기타 시장 예측과 부문 예측, 2018-2030년

제5장 미국의 의료기기 아웃소싱 시장 : 용도별, 추정 및 동향 분석

• 미국 의료기기 아웃소싱 시장(용도별) : 부문 대시보드
• 미국 의료기기 아웃소싱 시장(용도별) : 변동 분석
• 용도별, 2018-2030년
• 심장병학
  • 심장병학 시장 추정과 부문 예측, 2018-2030년
• 진단 이미지
  • 진단 화상 시장 추정과 부문 예측, 2018-2030년
• 정형외과
  • 정형외과시장 추정과 부문 예측, 2018-2030년
• 체외 진단 의료기기
  • 체외 진단용 의료기기 시장 추정과 부문 예측, 2018-2030년
• 안과
  • 안과 시장 예측과 부문별 예측(2018-2030년)
• 일반외과와 성형외과
  • 일반 외과와 형성 외과 시장 추정과 부문 예측, 2018-2030년
• 약물전달
  • 약물전달 시장의 추정과 부문 예측, 2018-2030년
  • 프리필드 주사기
  • 오토인젝터
  • 주입 펌프
  • 기타
• 치과
  • 치과 시장의 추정과 부문 예측, 2018-2030년
• 내시경 검사
  • 내시경 시장의 추정과 부문 예측, 2018-2030년
• 당뇨병 관리
  • 당뇨병 관리 시장의 추정과 부문 예측, 2018-2030년
• 기타
  • 기타 시장 예측과 부문 예측, 2018-2030년

제6장 미국의 의료기기 아웃소싱 시장 : 클래스별, 추정·동향 분석

• 미국의 의료기기 아웃소싱 시장(클래스별) : 부문 대시보드
• 미국의 의료기기 아웃소싱 시장(클래스별) : 변동 분석
• 클래스별, 2018-2030년
• 클래스 I
  • 클래스 I 의료기기 아웃소싱 시장의 추정과 부문 예측, 2018-2030년
• 클래스 II
  • 클래스 II 의료기기 아웃소싱 시장의 추정과 부문 예측, 2018-2030년
• 클래스 III
  • 클래스 III 의료기기 아웃소싱 시장의 추정과 부문 예측, 2018-2030년

제7장 미국의 의료기기 아웃소싱 시장 : 최종 용도별, 추정·동향 분석

• 미국의 의료기기 아웃소싱 시장(최종 용도별) : 부문 대시보드
• 미국의 의료기기 아웃소싱 시장(최종 용도별) : 변동 분석
• 용도별, 2018-2030년
• 심장병학
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 진단 이미지
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 정형외과
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 체외 진단용 의약품
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 안과
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 일반외과와 성형외과
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 약물전달
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 치과
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 내시경 검사
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 당뇨병 관리
  • 클래스 I
  • 클래스 II
  • 클래스 III
• 기타
  • 클래스 I
  • 클래스 II
  • 클래스 III

제8장 경쟁 구도

• 기업 분류
  • 마켓 리더
  • 신흥 진출기업
• 시장 포지셔닝 분석, 2024년(히트 맵 분석)
• 기업 프로파일
  • SGS SA
  • Laboratory Corporation Of America Holdings
  • Eurofins Scientific
  • Pace Analytical Services, Inc.
  • TUV SUD
  • Charles River Laboratories
  • Freyr
  • Global Regulatory Partners
  • Parexel International Corporation
  • Genpact
  • Criterium, Inc.
  • Promedica International
  • Medpace
  • ICON Plc.
  • IQVIA Inc.
  • Integer Holdings Corporation
  • Jabil Inc.
  • Flex Ltd.
  • Plexus Corp.
  • West Pharmaceutical Services, Inc.

SHW

영문 목차

영문목차

U.S. Medical Device Outsourcing Market Growth & Trends:

The U.S. medical device outsourcing market size is expected to reach USD 63.40 billion in 2030 and is expected to grow at a CAGR of 13.0% over the forecast period, according to a new report by Grand View Research, Inc. This market is growing as a result of increased offshore trends, a rise in demand for high-tech medical devices, and stringent regulation for medical devices in the U.S.

The medical device industry has always been highly competitive, and categories such as coronary stents, orthopedic devices, and wound care are moving toward maturity. As high-impact scientific innovation in the above categories is difficult to achieve and is a time-consuming process, smaller companies are gaining market share by offering low prices and introducing innovative business models. Due to the convergence of mounting challenges and changing market dynamics, medical device manufacturers are likely to opt for outsourcing business models to reduce costs, manage business risks, and improve service delivery. This factor is expected to propel market growth over the forecast period.

The government authorities have escalated funds for the research and development of essential devices, thus driving the market. The majority of clinical research globally devices are conducted in the U.S. alone according to Clinical Trials .gov. In case of the medical device also significant studies are conducted in the U.S.

For instance, as of February 2023, over 25033, research for medical devices was registered in the Clinical Trials .gov. Medical device companies are conducting research in the country owing to the availability of skilled labor and advanced infrastructure, as well as the presence of a significant number of CROs offering quality services. All these factors are expected to support the market in the post-Pandemic period.

U.S. Medical Device Outsourcing Market Report Highlights:

• The U.S. medical device outsourcing industry is developing due to stricter FDA regulations, which require manufacturers to seek specialized compliance support
• The market is rapidly transforming due to evolving regulatory requirements, cost pressures, and the need for faster time to market
• The U.S. medical device outsourcing industry is driven by cost containment pressures, stringent regulatory compliance, and increasing complexity in device development.
• The contract manufacturing segment accounted for the largest share of 46.74% in 2024. The segment growth is owing to increasing cost pressures, stringent FDA regulatory requirements, and the growing complexity of medical devices
• Based on application, the cardiology segment dominated the market in 2024. The growing demand for cardiovascular devices due to the high prevalence rate of cardiovascular diseases (CVDs) is attributed to the growth of outsourcing these devices

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Purchased Database
  • 1.3.3. GVR's Internal Database
  • 1.3.4. Secondary Sources
  • 1.3.5. Primary Research
• 1.4. Information or Data Analysis
  • 1.4.1. Information Analysis
  • 1.4.2. Market Formulation & Data Visualization
  • 1.4.3. Data Validation & Publishing
• 1.5. Model Details
  • 1.5.1. Commodity Flow Analysis (Model 1)
  • 1.5.2. Top Down Market Estimation (Model 2)
  • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
  • 1.5.4. Multivariate Analysis (Model 4)
  • 1.5.5. Bottom-Up Approach (Model 5)
• 1.6. List of Secondary Sources
• 1.7. List of Abbreviations
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Changing Regulatory Landscape
    • 3.2.1.2. Increase in the Offshoring of Medical Device Manufacturing
    • 3.2.1.3. Rising Demand for Advanced Products
    • 3.2.1.4. Implementation of International Standards by Contract Manufacturers
    • 3.2.1.5. Rising Price Competition and the Need to Reduce Costs
    • 3.2.1.6. Increasing Complexity in Product Design and Engineering
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Compliance Issues While Outsourcing
    • 3.2.2.2. Regulatory and Legal Compliance
    • 3.2.2.3. Contractual Obligations
  • 3.2.3. Industry Challenges
    • 3.2.3.1. Managing Relationships
• 3.3. Technological Advancements
• 3.4. Regulatory Framework
• 3.5. Pricing Model Analysis
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. U.S. Medical Device Outsourcing Market: Service Estimates & Trend Analysis

• 4.1. U.S. Medical Device Outsourcing Market, By Service: Segment Dashboard
• 4.2. U.S. Medical Device Outsourcing Market, By Service: Movement Analysis
• 4.3. U.S. Medical Device Outsourcing Market Estimates & Forecasts, By Service, 2018 - 2030
• 4.4. Quality Assurance Services
  • 4.4.1. Quality Assurance Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.5. Regulatory Affairs Services
  • 4.5.1. Regulatory Affairs Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.5.2. Clinical Trial Applications & Product Registration
    • 4.5.2.1. Clinical Trial Applications & Product Registration Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.5.3. Regulatory Writing & Publishing
    • 4.5.3.1. Regulatory Writing & Publishing Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.5.4. Legal Representation
    • 4.5.4.1. Legal Representation Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.6. Product Design and Development Services
  • 4.6.1. Product Design and Development Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.6.2. Designing & Engineering
    • 4.6.2.1. Designing & Engineering Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.6.3. Machining
    • 4.6.3.1. Machining Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.6.4. Molding
    • 4.6.4.1. Molding Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.6.5. Packaging
    • 4.6.5.1. Packaging Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.7. Data Management and Biostatistics
  • 4.7.1. Data Management and Biostatistics Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.8. Product Testing & Sterilization Services
  • 4.8.1. Product Testing & Sterilization Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.9. Product Implementation Services
  • 4.9.1. Product Implementation Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.10. Product Upgrade Services
  • 4.10.1. Product Upgrade Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.11. Product Maintenance Services
  • 4.11.1. Product Maintenance Services Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.12. Contract Manufacturing
  • 4.12.1. Contract Manufacturing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.12.2. Accessories Manufacturing
    • 4.12.2.1. Accessories Manufacturing Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.12.3. Assembly Manufacturing
    • 4.12.3.1. Assembly Manufacturing Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.12.4. Component Manufacturing
    • 4.12.4.1. Component Manufacturing Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 4.12.5. Device Manufacturing
    • 4.12.5.1. Device Manufacturing Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 4.13. Others
  • 4.13.1. Others Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Medical Device Outsourcing Market: Application Estimates & Trend Analysis

• 5.1. U.S. Medical Device Outsourcing Market, By Application: Segment Dashboard
• 5.2. U.S. Medical Device Outsourcing Market, By Application: Movement Analysis
• 5.3. U.S. Medical Device Outsourcing Market Estimates & Forecasts, By Application, 2018 - 2030
• 5.4. Cardiology
  • 5.4.1. Cardiology Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.5. Diagnostic Imaging
  • 5.5.1. Diagnostic Imaging Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.6. Orthopedic
  • 5.6.1. Orthopedic Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.7. IVD
  • 5.7.1. IVD Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.8. Ophthalmic
  • 5.8.1. Ophthalmic Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.9. General & Plastic Surgery
  • 5.9.1. General & Plastic Surgery Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.10. Drug Delivery
  • 5.10.1. Drug Delivery Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 5.10.2. Prefilled Syringe
    • 5.10.2.1. Prefilled Syringe Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 5.10.3. Autoinjectors
    • 5.10.3.1. Autoinjectors Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 5.10.4. Infusion Pump
    • 5.10.4.1. Infusion Pump Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 5.10.5. Others
    • 5.10.5.1. Others Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.11. Dental
  • 5.11.1. Dental Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.12. Endoscopy
  • 5.12.1. Endoscopy Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.13. Diabetes Care
  • 5.13.1. Diabetes Care Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 5.14. Others
  • 5.14.1. Others Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Medical Device Outsourcing Market: Class Estimates & Trend Analysis

• 6.1. U.S. Medical Device Outsourcing Market, By Class: Segment Dashboard
• 6.2. U.S. Medical Device Outsourcing Market, By Class: Movement Analysis
• 6.3. U.S. Medical Device Outsourcing Market Estimates & Forecasts, By Class, 2018 - 2030
• 6.4. Class I
  • 6.4.1. Class I Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.5. Class II
  • 6.5.1. Class II Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 6.6. Class III
  • 6.6.1. Class III Medical Device Outsourcing Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 7. U.S. Medical Device Outsourcing Market: End Use Estimates & Trend Analysis

• 7.1. U.S. Medical Device Outsourcing Market, By End Use: Segment Dashboard
• 7.2. U.S. Medical Device Outsourcing Market, By End Use: Movement Analysis
• 7.3. U.S. Medical Device Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030
• 7.4. Cardiology
  • 7.4.1. Class I
    • 7.4.1.1. Class I Cardiology Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.4.2. Class II
    • 7.4.2.1. Class II Cardiology Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.4.3. Class III
    • 7.4.3.1. Class III Cardiology Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.5. Diagnostic Imaging
  • 7.5.1. Class I
    • 7.5.1.1. Class I Diagnostic Imaging Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.5.2. Class II
    • 7.5.2.1. Class II Diagnostic Imaging Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. Class III
    • 7.5.3.1. Class III Diagnostic Imaging Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.6. Orthopedic
  • 7.6.1. Class I
    • 7.6.1.1. Class I Orthopedic Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.6.2. Class II
    • 7.6.2.1. Class II Orthopedic Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.6.3. Class III
    • 7.6.3.1. Class III Orthopedic Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.7. IVD
  • 7.7.1. Class I
    • 7.7.1.1. Class I IVD Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.7.2. Class II
    • 7.7.2.1. Class II IVD Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.7.3. Class III
    • 7.7.3.1. Class III IVD Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.8. Ophthalmic
  • 7.8.1. Class I
    • 7.8.1.1. Class I Ophthalmic Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.8.2. Class II
    • 7.8.2.1. Class II Ophthalmic Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.8.3. Class III
    • 7.8.3.1. Class III Ophthalmic Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.9. General & Plastic Surgery
  • 7.9.1. Class I
    • 7.9.1.1. Class I General & Plastic Surgery Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.9.2. Class II
    • 7.9.2.1. Class II General & Plastic Surgery Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.9.3. Class III
    • 7.9.3.1. Class III General & Plastic Surgery Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.10. Drug Delivery
  • 7.10.1. Class I
    • 7.10.1.1. Class I Drug Delivery Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.10.2. Class II
    • 7.10.2.1. Class II Drug Delivery Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.10.3. Class III
    • 7.10.3.1. Class III Drug Delivery Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.11. Dental
  • 7.11.1. Class I
    • 7.11.1.1. Class I Dental Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.11.2. Class II
    • 7.11.2.1. Class II Dental Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.11.3. Class III
    • 7.11.3.1. Class III Dental Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.12. Endoscopy
  • 7.12.1. Class I
    • 7.12.1.1. Class I Endoscopy Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.12.2. Class II
    • 7.12.2.1. Class II Endoscopy Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.12.3. Class III
    • 7.12.3.1. Class III Endoscopy Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.13. Diabetes Care
  • 7.13.1. Class I
    • 7.13.1.1. Class I Diabetes Care Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.13.2. Class II
    • 7.13.2.1. Class II Diabetes Care Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.13.3. Class III
    • 7.13.3.1. Class III Diabetes Care Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
• 7.14. Others
  • 7.14.1. Class I
    • 7.14.1.1. Class I Others Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.14.2. Class II
    • 7.14.2.1. Class II Others Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)
  • 7.14.3. Class III
    • 7.14.3.1. Class III Others Market Estimates and Segment Forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
  • 8.1.1. Market Leaders
  • 8.1.2. Emerging Players
• 8.2. Market Position Analysis, 2024 (Heat Map Analysis)
• 8.3. Company Profiles
  • 8.3.1. SGS SA
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Laboratory Corporation Of America Holdings
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Eurofins Scientific
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Pace Analytical Services, Inc.
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. TUV SUD
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Charles River Laboratories
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Freyr
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. Global Regulatory Partners
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Parexel International Corporation
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Genpact
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Criterium, Inc.
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Service Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. Promedica International
    • 8.3.12.1. Company Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Service Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. Medpace
    • 8.3.13.1. Company Overview
    • 8.3.13.2. Financial Performance
    • 8.3.13.3. Service Benchmarking
    • 8.3.13.4. Strategic Initiatives
  • 8.3.14. ICON Plc.
    • 8.3.14.1. Company Overview
    • 8.3.14.2. Financial Performance
    • 8.3.14.3. Service Benchmarking
    • 8.3.14.4. Strategic Initiatives
  • 8.3.15. IQVIA Inc.
    • 8.3.15.1. Company Overview
    • 8.3.15.2. Financial Performance
    • 8.3.15.3. Service Benchmarking
    • 8.3.15.4. Strategic Initiatives
  • 8.3.16. Integer Holdings Corporation
    • 8.3.16.1. Company Overview
    • 8.3.16.2. Financial Performance
    • 8.3.16.3. Service Benchmarking
    • 8.3.16.4. Strategic Initiatives
  • 8.3.17. Jabil Inc.
    • 8.3.17.1. Company Overview
    • 8.3.17.2. Financial Performance
    • 8.3.17.3. Service Benchmarking
    • 8.3.17.4. Strategic Initiatives
  • 8.3.18. Flex Ltd.
    • 8.3.18.1. Company Overview
    • 8.3.18.2. Financial Performance
    • 8.3.18.3. Service Benchmarking
    • 8.3.18.4. Strategic Initiatives
  • 8.3.19. Plexus Corp.
    • 8.3.19.1. Company Overview
    • 8.3.19.2. Financial Performance
    • 8.3.19.3. Service Benchmarking
    • 8.3.19.4. Strategic Initiatives
  • 8.3.20. West Pharmaceutical Services, Inc.
    • 8.3.20.1. Company Overview
    • 8.3.20.2. Financial Performance
    • 8.3.20.3. Service Benchmarking
    • 8.3.20.4. Strategic Initiatives

관련자료